CAR-T 치료법은 최근 수술, 화학요법, 방사선 치료보다 선호되고 있습니다. 이 치료법은 암세포를 표적으로 삼아 종양에 대한 환자의 면역 체계를 강화합니다. 이것은 암세포를 공격하는 T세포에 특수 단백질 수용체를 추가하여 환자의 혈액에서 추출한 T세포를 실험실에서 변형시키는 일종의 치료법입니다.
시장 역학
CAR-T 치료 시장은 대체 치료법에 실패한 환자 수가 증가하는 등의 추진 요인으로 인해 예측 기간 동안 성장할 것으로 예상됩니다. , 암 환자 수의 증가 및 새롭고 효과적인 치료법 개발. 그럼에도 불구하고 사이토카인 방출 증후군과 같은 부작용과 발작, 섬망 등의 신경학적 문제는 예측 기간 동안 시장 성장에 방해가 될 수 있습니다.
시장 범위
"2031년까지의 글로벌 CAR-T 치료 시장 분석"은 특히 다음에 초점을 맞춘 생명공학 산업에 대한 전문적이고 심층적인 연구입니다. 글로벌 시장 동향 분석. 이 보고서는 복용량, 투여 경로, 적용 및 지역별로 상세한 시장 세분화를 통해 CAR-T 치료 시장에 대한 개요를 제공하는 것을 목표로 합니다. 글로벌 CAR-T 치료 시장은 예측 기간 동안 높은 성장을 보일 것으로 예상됩니다. 이 보고서는 주요 CAR-T 치료 시장 플레이어의 시장 상태에 대한 주요 통계를 제공하고 시장의 주요 추세와 기회를 제공합니다.
시장 세분화
글로벌 CAR-T 치료 시장은 표적 항원 및 치료 적용을 기준으로 분류됩니다. 표적 항원을 기준으로 시장은 CD 19, BCMA, HER2, GD2, CD 20, CD22, CD30, CD33, HER1 및 기타로 분류됩니다. 치료 적용을 기준으로 시장은 급성 림프구성 백혈병, 만성 림프구성 백혈병, 미만성 거대 B 세포 림프종, 여포성 림프종, 다발성 골수종, 교모세포종, 육종, 신경모세포종, 급성 골수성 백혈병, 유방암, 췌장암, 간세포 암종으로 분류됩니다. , 대장암 및 기타
이 보고서는 질적 및 양적 정보를 모두 포함하여 업계에 대한 자세한 개요를 제공합니다. 다양한 부문을 기반으로 하는 글로벌 CAR-T 치료 시장에 대한 개요 및 예측을 제공합니다. 또한 5개 주요 지역에 대해 2021년부터 2031년까지 시장 규모와 예측 추정치를 제공합니다. 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA) 및 남부 & 중앙 아메리카. 각 지역별 CAR-T 치료 시장은 나중에 각 국가 및 부문별로 세분화됩니다. 이 보고서는 전 세계 18개국에 대한 분석 및 예측과 함께 이 지역에 널리 퍼져 있는 현재 동향 및 기회를 다루고 있습니다.
이 보고서는 수요와 공급 측면에서 CAR-T 치료 시장에 영향을 미치는 요인을 분석하고 시장 역학을 추가로 평가합니다. 예측 기간 동안 시장에 영향을 미칩니다(예: 동인, 제약, 기회 및 미래 추세). 이 보고서는 또한 5개 지역 모두에 대한 철저한 PEST 분석을 제공합니다. 북미, 유럽, APAC, MEA 및 남부 & 중앙아메리카는 이 지역의 CAR-T 치료 시장에 영향을 미치는 정치적, 경제적, 사회적 및 기술적 요인을 평가한 후입니다.
시장 플레이어
이 보고서는 유기 및 무기 성장 전략으로서 CAR-T 치료 시장의 주요 개발을 다룹니다. 다양한 기업들이 제품 출시, 제품 승인, 특허, 이벤트 등 유기적인 성장 전략에 주력하고 있습니다. 시장에서 목격된 무기 성장 전략 활동은 인수 및 파트너십 & 협력. 이러한 활동은 시장 참가자의 비즈니스 및 고객 기반 확장을 위한 길을 열었습니다. CAR-T 치료 시장의 시장 지불자는 글로벌 시장에서 CAR-T 치료에 대한 수요가 증가함에 따라 향후 수익성 있는 성장 기회가 있을 것으로 예상됩니다. 아래에는 CAR-T 치료 시장에 참여하는 몇몇 회사 목록이 나와 있습니다.
이 보고서에는 SWOT 분석 및 시장 전략과 함께 주요 CAR-T 치료 시장 기업의 프로필도 포함되어 있습니다. 또한 이 보고서는 회사 프로필, 제공되는 구성 요소 및 서비스, 지난 3년간의 재무 정보, 지난 5년간의 주요 개발과 같은 정보를 제공하는 업계 선두 기업에 중점을 두고 있습니다.
- Novartis International AG< /li>
- Kite Pharma, Inc.(Gilead Sciences, Inc.)
- Juno Therapeutics(Celgene Corporation)
- Bluebird Bio, Inc.(Celgene Corporation)
- Sorrento Therapeutics Inc.
- Mustang Bio, Inc.
- Aurora Biopharma Inc.
- Legend Biotech(Genscript Biotech Corporation)
- Pfizer, Inc.
- CARsgen Therapeutics, Ltd.
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Players operating in the market are Bristol Myers Squibb, Immunocore Holdings, Legend Biotech, Jenssen Global Services, Gilead Sciences, Bluebird Bio, Novatis AG, and JW Therapeutics
Acute Lymphocytic Leukemia segment, by therapeutic appication, dominated the market in 2023.
North America region dominated the CAR-T therapy market in 2023.
Growing Investment in CAR-T Therapy act as a opportunity for growth of the market in forecast period.
The CAR-T Therapy Market is estimated to witness a CAGR of 16.2% from 202#to 2031
The major factors driving the CAR-T therapy market are:
1. Incidence of Cancer
2.CAR-T approvals
Trends and growth analysis reports related to Life Sciences : READ MORE..
1. Novartis International AG
2. Kite Pharma, Inc. (Gilead Sciences, Inc.)
3. Juno Therapeutics (Celgene Corporation)
4. Bluebird Bio, Inc. (Celgene Corporation)
5. Sorrento Therapeutics Inc.
6. Mustang Bio, Inc
7. Aurora Biopharma Inc.
8. Legend Biotech (Genscript Biotech Corporation)
9. Pfizer, Inc.
10. CARsgen Therapeutics, Ltd.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.